{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:35:13Z","timestamp":1792895713105,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.07.017","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T23:33:09Z","timestamp":1786059189000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T-cell\u2013biased IL-2 mutein inhibits development of allergen-specific TH2 cells and allergic asthma"],"prefix":"10.1016","author":[{"given":"Amandine","family":"Selle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Yero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-7912","authenticated-orcid":false,"given":"Andrew D.","family":"Luster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.017_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.017_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.25","article-title":"Asthma","volume":"1","author":"Holgate","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2026.07.017_bib3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1046\/j.1365-2745.2002.01455.x","article-title":"Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and\/or rhinitis","volume":"32","author":"Trombone","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.07.017_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cea.14575","article-title":"Allergen immunotherapy for the prevention and treatment of asthma","volume":"55","author":"Batard","year":"2025","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2026.07.017_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41533-024-00411-9","article-title":"Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus","volume":"35","author":"Skolnik","year":"2025","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib7","article-title":"Contribution of regulatory T cell methylation modifications to the pathogenesis of allergic airway diseases","author":"Li","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2026.07.017_bib8","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1172\/JCI69355","article-title":"Itch expression by Treg cells controls Th2 inflammatory responses","volume":"123","author":"Jin","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.017_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ni.3083","article-title":"Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo","volume":"16","author":"Ulges","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.07.017_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0140-6736(04)15592-X","article-title":"Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease","volume":"363","author":"Ling","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.07.017_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.immuni.2008.05.010","article-title":"Adaptive Foxp3+ regulatory T cell\u2013dependent and \u2013independent control of allergic inflammation","volume":"29","author":"Curotto de Lafaille","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.07.017_bib13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1084\/jem.20060155","article-title":"Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells","volume":"203","author":"Strickland","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.20051166","article-title":"Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent","volume":"202","author":"Kearley","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib15","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/nm.2896","article-title":"Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma","volume":"18","author":"Krishnamoorthy","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1165\/rcmb.2010-0001OC","article-title":"Regulatory T cells contribute to allergen tolerance induced by daily airway immunostimulant exposures","volume":"44","author":"Lee","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2026.07.017_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.molimm.2007.05.030","article-title":"Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen","volume":"45","author":"Marazuela","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mi.2013.107","article-title":"Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi","volume":"7","author":"Bacher","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm745","article-title":"Antigen-specific regulatory T cells develop via the ICOS\u2013ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity","volume":"8","author":"Akbari","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib20","article-title":"Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic airway disease in mice","author":"Emiliano G\u00f3mez Medell\u00edn","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib21","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190865","article-title":"Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease","volume":"217","author":"Rahimi","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221094","article-title":"T helper 2 cells in asthma","volume":"220","author":"Harker","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30259-2","article-title":"Chitin promotes antigen-specific Th2 cell\u2013mediated murine asthma through induction of IL-33\u2013mediated IL-1\u03b2 production by DCs","volume":"8","author":"Arae","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.07.017_bib24","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.20051506","article-title":"CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function","volume":"202","author":"Lewkowich","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.017_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell\u2013based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.07.017_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and Function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2015.11.004","article-title":"Interleukin-2\u2013dependent allergen-specific tissue-resident memory cells drive asthma","volume":"44","author":"Hondowicz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.07.017_bib29","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41590-024-01986-8","article-title":"Spatial microniches of IL-2 combine with IL-10 to drive lung migratory TH2 cells in response to inhaled allergen","volume":"25","author":"He","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ni.2030","article-title":"Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages","volume":"12","author":"Liao","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/cei\/uxac105","article-title":"IL-2\u2013based approaches to Treg enhancement","volume":"211","author":"Harris","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.5152\/dir.2021.20503","article-title":"High-dose interleukin-2 therapy related adverse events and implications on imaging","volume":"27","author":"Shah","year":"2021","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.jaci.2026.07.017_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104539","article-title":"A systematic review of interleukin-2\u2013based immunotherapies in clinical trials for cancer and autoimmune diseases","volume":"90","author":"Raeber","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaci.2026.07.017_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102554","article-title":"Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity","volume":"94","author":"Wright","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100103","article-title":"NKTR-358: a novel regulatory T-cell stimulator that selectively stimulates expansion and suppressive function of regulatory T cells for the treatment of autoimmune and inflammatory diseases","volume":"4","author":"Dixit","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jaci.2026.07.017_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100152","article-title":"Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus","volume":"5","author":"Fanton","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jaci.2026.07.017_bib37","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.4049\/jimmunol.1800907","article-title":"IL-2\/CD25: a long-acting fusion protein that promotes immune tolerance by selectively targeting the IL-2 receptor on regulatory T cells","volume":"201","author":"Ward","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/ITT.S500229","article-title":"Cytokine couture: designer IL2 molecules for the treatment of disease","volume":"14","author":"Dashwood","year":"2025","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.jaci.2026.07.017_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.10.017","article-title":"A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease","volume":"95","author":"Peterson","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2026.07.017_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114938","article-title":"An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy","volume":"43","author":"Jamison","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2026.07.017_bib41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173107","article-title":"A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models","volume":"134","author":"Efe","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.017_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/immunohorizons.2100051","article-title":"In vivo expansion of antigen-specific regulatory T cells through staggered Fc.IL-2 mutein dosing and antigen-specific immunotherapy","volume":"5","author":"Pham","year":"2021","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jaci.2026.07.017_bib45","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2024.10.033","article-title":"Low-dose IL-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial","volume":"155","author":"Rosenzwajg","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlaf005","article-title":"Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data","volume":"9","author":"Scheid","year":"2025","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jaci.2026.07.017_bib47","doi-asserted-by":"crossref","first-page":"9230","DOI":"10.1038\/s41467-024-53384-1","article-title":"The regulatory T cell\u2013selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials","volume":"15","author":"Silverberg","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.07.017_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jaci.2026.07.017_bib49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaci.2013.03.002","article-title":"Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation","volume":"131","author":"Afshar","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib50","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.181.10.6889","article-title":"Differential regulatory function of resting and preactivated allergen-specific CD4+CD25+ regulatory T cells in Th2-type airway inflammation","volume":"181","author":"Saito","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-7896-0_14","article-title":"Generation of Allergen-Specific Tetramers for a Murine Model of Airway Inflammation","volume":"1799","author":"Moon","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2026.07.017_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10772","article-title":"Extrathymically generated regulatory T cells control mucosal TH2 inflammation","volume":"482","author":"Josefowicz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.07.017_bib54","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jaci.2015.03.043","article-title":"IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation","volume":"136","author":"Roediger","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib55","article-title":"Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2026.07.017_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37424-w","article-title":"Low-dose IL-2 enhances the generation of IL-10\u2013producing immunoregulatory B cells","volume":"14","author":"Inaba","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.07.017_bib57","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0903940","article-title":"Cutting edge: mechanisms of IL-2\u2013dependent maintenance of functional regulatory T cells","volume":"185","author":"Barron","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.017_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41590-018-0280-2","article-title":"Regulatory T cells mediate specific suppression by depleting peptide\u2013MHC class II from dendritic cells","volume":"20","author":"Akkaya","year":"2019","journal-title":"Nat Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:00:50Z","timestamp":1792893650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926005609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"alternative-id":["S0091674926005609"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.017","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T-cell\u2013biased IL-2 mutein inhibits development of allergen-specific TH2 cells and allergic asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}